|
|
Subscribe to EFPIA's latest News |
- AstraZeneca vs Commission, European General Court judgment of 1 July 2010 (Case T-321/05)
(1/07/2010)
Today, the European General Court has confirmed the Commission’s broad margin of discretion in making complex economic appraisals in defining the relevant market and finding dominance.
- "EFPIA Leadership Statement on Ethical Practices"
Industry restricts product sampling and sets new standards for sales representatives and congresses (24/06/2010)
EFPIA released a statement on behalf of the association leadership regarding industry standards. The statement, agreed by industry leaders, provides EFPIA and its member associations with a clear mandate to champion and enforce the highest possible standards by reviewing a number of areas and, where necessary, issuing additional guidance.
- President of EFPIA calls for a 'new dialogue' on medicines - Access and affordability the key questions for European decision-makers; more patient focussed policies required (21/06/2010)
Andrew Witty, CEO of GlaxoSmithKline and President of EFPIA, called today for 'a new dialogue’ between governments and the pharmaceutical industry in order to deliver patient access to better medicines and enhance Europe’s competitiveness as a base for R&D investment.
- New EFPIA Member of Governing Board of Innovative Medicines Initiative (18/05/2010)
EFPIA confirmed that Mr. Roch Doliveux, CEO of global biopharmaceutical company UCB and EFPIA board member, has been appointed to the Governing Board of the Innovative Medicines Initiative (IMI), a public-private partnership between the EFPIA and the European Union.
- Agreement on animal welfare legislation: a step forward for patients, research and animal welfare (11/05/2010)
EFPIA acknowledges the Council’s adoption of the common position on the revision of EU Directive on the protection of laboratory animals. This paves the way for a rapid completion of the new legislation and improving and harmonising animal protection standards.
- EFPIA anti-counterfeit product verification pilot project successful (14/04/2010)
EFPIA today published the results of their product verification system pilot project. The pilot, held in Sweden, between September 2009 and January 2010, successfully demonstrated that a product verification system at the point of dispense, based on a two-dimensional data matrix, is both robust and effective.
|
|
|
| EFPIA Commentary |
|
|
|
|
13-14 September 2010
- Pediatric Pharmacology Europe
Utilising advanced methodologies & technologies to improve drug development for children Location: Brussels/Belgium
This focused and interactive Conference will look to concentrate on the importance and place of pharmacokinetic and pharmacodynamic studies to answer the questions of how children metabolize drugs differently. It will explore the best use of modeling and simulations, what extrapolation is possible from existing data, how to assess optimal drug dosage levels, measure the drugs interactions on child physiology with minimal samples and subjects to optimise the design of studies for pediatric treatments. Read more...
20-23 September 2010
- Risk-based Control Strategies in Pharmaceutical Industries
Location: Brussels/Belgium
The ISPE Brussels Conference will offer Seminars and Training courses on various topics dedicated to science and manufacturing professionals. Through case studies and interactive workshops, attendees will have the opportunity to understand and take away practical examples on how principles of QbD can be applied to biotechnology, product development and manufacturing.
Another seminar will help participants to understand and develop new, lean and efficient ways along the supply chain for IMPs while being compliant with clinical trials regulations globally.
The overhaul aim of this conference is to provide industry professionals the opportunity to learn from leaders and innovators from across the globe on the topic of risk-based control strategies. Read more...
20-24 September 2010
- The INSEAD Healthcare Compliance Leadership Programme 2010/2011
Location: Fontainebleau/France
The INSEAD Healthcare Compliance Leadership Programme is designed for is designed for healthcare compliance executives in a mid-management or local role, and executives in related functions involved in compliance.
Its key objective is to develop the leadership competencies necessary to bring about effective compliance in healthcare companies.
Read more...
Registration forms can be found here.
14-15 October 2010
- Quality of medicines in a globalised world: dreams and reality
Location: Prague/Czech Republic
Medicines need to be safe, effective and of good quality. The EDQM contributes to this goal by establishing and providing standards, which apply to the manufacture and quality control of medicines in all the signatory states of the Convention for the elaboration of a European Pharmacopoeia and beyond. Providing good quality medicines or active pharmaceutical ingredients (APIs) is a global concern. This conference will bring together regulators, industry and trade associations and key stakeholders from around the world to discuss the challenges and issues surrounding the quality of medicines in a globalised world. Read more...
2-3 December 2010
- The Pan European Intellectual Property Summit Brussels IP2010 - A vision for Europe's IP
Location: Belgium/Brussels
The 4th IP Summit will once again raise the debates on patents and trademarks to new heights, with a unique double focus on major pan-European IP reforms at stake, as well as down-to-earth industry case-studies with truly practical answers. This Summit will focus around various topics:
- Community Patent
- Intellectual Property on the web
- IP Protection
- Global Knowledge Economy
- Threat or Opportunity of patents
On this 2day Seminar, 16 workshops will be organised around topics such as Patent Reforms, Trade Marks, Domain Names, IP & Competition, IP Taxation, IP Best Practices just to name a few. The various workshops will be business-focused and based on sound benchmarks and case studies.
Read more...
3 December 2010
- 21st Century Healthcare for Europe Belgian Senate
Conference by invitation only (info request: Xavier.hormaechea@ucb.com) Location: Brussels/Belgium
The main players in Europe’s healthcare sector have been invited by the Health, Science & Technology Group (HST) and EFPIA to attend a one-day conference to be held at the Belgian Senate, which will deal with two major topics:
- How to reduce inequalities in the provision of healthcare
- How to promote innovation in the healthcare sector
- The INSEAD Healthcare Compliance Leadership Programme 2010/2011
Location: Fontainebleau/France
The INSEAD Healthcare Compliance Leadership Programme is designed for is designed for healthcare compliance executives in a mid-management or local role, and executives in related functions involved in compliance.
Its key objective is to develop the leadership competencies necessary to bring about effective compliance in healthcare companies.
Read more...
Registration forms can be found here .
|
|
|